Arrhythmia

Research on arrhythmia reported by scientists at Technion, Medical Department

Published in Gene Therapy Weekly, July 31st, 2008

According to a study from Haifa, Israel, "Myocardial stem cell therapies are emerging as exciting new experimental strategies for treatment of a variety of cardiovascular disorders. This review describes the electrophysiologic implications associated with these emerging strategies."

"The electrophysiologic considerations associated with cell therapy for myocardial infarct repair are described from the mechanistic point of view (assessing electromechanical coupling between donor and host cells) and from the therapeutic (possibly preventing malignant ventricular arrhythmias) and potential adverse effects (increasing arrhythmogenesis) points of view. The potential of...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (2008-07-31)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry